Product category:
Liquid Analysis: Spectroscopy, Colour
News Release from: Centice | Subject: Pharma verification
Edited by the Processingtalk Editorial
Team on 10 December 2007
Non contact pharmaceutical
identification system
Centice Corporation has been awarded a patent for a breakthrough Rapid Pharmaceutical Verification and Identification System
Centice Corporation, a pioneer in next generation sensor technology, has announced that the company expanded its patent portfolio with the recent patent award for a "Rapid Pharmaceutical Verification and Identification System" This patent (US Patent No 7,218,395) describes a fully automated pharmaceutical identification and verification system that operates through a prescription vial or bottle without requiring cap removal/replacement, while providing superior verification speeds with higher accuracy
This article was originally published on Processingtalk on 31 Aug 2006 at 8.00am (UK)
Related stories
Multimodal multiplex spectroscopy developments
Centice Corporation has been awarded a patent for a breakthrough in multimodal multiplex spectroscopy technology, used for tissue spectroscopy and spectroscopic imaging
Oven temperature controllers
ABB Automation Technologies has supplied 12 ControlIT C351 single loop process controllers to Belgian chemical company Tessenderlo Chemie NV, to control six ovens in a continuous sulphate process
ABB adds single input versions to analyser range
ABB has launched single input versions of its AnalyzeIT AX400 pH/Redox and Conductivity analysers, with three alarm set points as standard
"We are very pleased with the award of this patent.
This patent is based upon the use of our previously patented Multimodal Multiplex Sensor platform technology," said Prasant Potuluri, PhD, CTO of Centice.
"This patent award demonstrates the applicability of the Centice core sensor technology to solve significant real-world problems".
Ray W Swanson, Centice president and CEO said: "The PASS Rx pharmaceutical authentication sensor system, planned for 2008 availability, will improve patient safety by enhancing the quality assurance process for dispensed medications".
Centice designs and manufactures computational sensors which enable a new generation of high sensitivity molecular spectrometers and analysers.
Centice is the exclusive licensee of the coded optical sensor technology first developed at Duke University under NIH and DARPA grants for tissue spectroscopy and spectroscopic imaging.
To date, the company has five issued patents and twelve filed patent applications.
• Centice: contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page
Search the Pro-Talk network of sites
